Company intelligence / Profile preview

Arcaea

Boston, Massachusetts, United Statesarcaea.lowiro.com ↗

Ownership: Private
Development stage: Commercial

Overview

Arcaea develops novel beauty and personal care ingredients using biotechnology. Their approach enables sustainable production of new molecules previously inaccessible through traditional chemistry or extraction. They have launched ingredient technologies such as ScentARC for deodorant applications and acquired Gadusol Laboratories to accelerate development of biologically derived sunscreen compounds

Modalities: BiologicSmall molecule
Industry: Non-Drug Biotech

Partnerships

Ginkgo Bioworks

Beyond the preview

Go deeper on Arcaea.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Arcaea.

Explore the full profile